Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Stroke Motor Rehabilitation and Recovery Study

Key facts

Where
Boston, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Source: NCT03485040, who can take part

Where in United States

  • Massachusetts General HospitalBoston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Massachusetts General Hospital
Trial code
NCT03485040
Record updated
15 May 2025
Original description
SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.Read full original descriptionShow less

Defining the Trajectory of Motor Recovery After Stroke

SMaHRT (Stroke Motor reHabiliation and Recovery sTudy) is a longitudinal study aimed at understanding the natural history of upper extremity motor recovery after ischemic and hemorrhagic stroke.

Inclusion: Age 18 - 90; Upper extremity motor weakness after ischemic and/or hemorrhagic stroke as defined by a score of >=1 on NIH Stroke Scale Arm Motor Drift Questions 5A or 5B; Ability to follow simple commands in English; Score of zero or 1 on the NIH Stroke Scale Level of Consciousness Questions 1a and 1b and a score of zero on the NIH Stroke Scale Level of Consciousness Question 1c; Stable medical status as determined by primary care team; Inpatient on the MGH stroke neurology service.

Exclusion: Prior history of developmental, neurologic, or major psychiatric disorder resulting in functional disability; Prior history of visual or auditory disorders limiting ability to participate in testing; Evidence of an uncontrolled seizure disorder; Patients for whom EEG leads are contraindicated.

ClinicalTrials.gov NCT03485040